Numeco, an affiliate of the botulinum toxin (BTX) maker Medytox, said the Ministry of Food and Drug Safety has approved Newlux, a next-generation BTX product.Newlux, Numeco's first BTX preparation, is a next-generation toxin preparation in a freeze-dried powder formulation.The BTX is characterized b
Three first-year medical residents have recently left the pediatrics department at Seoul National University Hospital.The collapse of the pediatric healthcare delivery system, which has gradually progressed in provincial hospitals, finally reached the Seoul National University Hospital, shaking even
AVEO Pharmaceuticals, a subsidiary of LG Chem, has completed the U.S. phase 2 clinical trial of ficlatuzumab, a head and neck cancer candidate, and published the results in an international journal.As the LG Group has recently shown its commitment to developing new drugs, LG Chem's plans are drawing
The recent buzz in the Korean stock market revolves around the ambitious Cancer Moonshot Initiative, which aims to reduce the death rate from cancer by more than 50 percent over the next 25 years, propelled by U.S. President Joe Biden's administration.The interest in the Cancer Moonshot Initiative s
Huons said it has recently renewed its agreement with Biosyn Korea, the Korean offshoot of Biosyn Arzneimittel GmbH, a German pharmaceutical company, for the exclusive domestic distribution rights of Selenase, a selenium deficiency treatment.This agreement is an extension of the existing exclusive d
The National Health Insurance Service (NHIS), which has been in a legal battle against tobacco companies for damage compensation worth 53.3 billion won ($40.4 million) for nine years, draws renewed attention by presenting results that prove the causal link between smoking and cancer.In 2014, NHIS fi
H·ROBOTICS, a robotics-based healthcare company that attracts the rehabilitation medical equipment industry’s attention, will showcase its flagship products at the K-HOSPITAL HEALTH TECH FAIR 2023 (KHF 2023), at COEX from Sept. 14 to 16.The company said Friday that it would exhibit its two mainstay
Hugel said it has resubmitted its new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for 50 and 100 units of Letybo (brand name in Korea: Botulax), its botulinum toxin (BTX) preparation.The NDA is the third challenge after the company received supplemental requests for the las
When I engage in discussions with people about adopting a slow-aging lifestyle, I often receive this common question: “Doesn't maintaining habits like eating balanced meals, staying physically active, and prioritizing restful sleep become stressful, possibly leading to illness?” This question typica
As the increasing demand for transplants cannot be filled with human-to-human organ transplants, this has shifted the focus to animal-to-human transplants, better known as xenotransplants.Accordingly, Optipharm CEO Kim Hyun-il revealed that his company is planning to fill this void and is currently
Korea is expected to become one of three nations that have succeeded in developing an anthrax vaccine after developing the vaccine for 26 years.The Korea Disease Control and Prevention Agency (KCDA) said Thursday that it will apply for a product license for a domestically developed anthrax vaccine t
Celltrion said it has completed a marketing authorization application for CT-P43, a biosimilar referencing Stelara (ustekinumab) that treats autoimmune diseases, to Australia’s Therapeutic Goods Administration (TGA) on Thursday (local time).Celltrion filed a marketing authorization application in Au
Quite a few people believe Korean doctors make more money than their colleagues in the Organization for Economic Cooperation and Development (OECD) countries.However, a doctors' group said that the belief, based on the OECD Health Statistics, is misguided, resulting from the distorted data analysis.
QuantaMatrix, an in vitro diagnostics company, said on Thursday that it won a tender valued at €11 million ($15.4 billion) to exclusively supply its direct & Rapid Antimicrobial Susceptibility Test (dRAST) for four years to public hospitals in France. QuantaMatrix was selected by Union des Hôpitaux
Vyvgart (efgartigimod), a breakthrough treatment for generalized myasthenia gravis (gMG), will be introduced in Korea.Handok said Wednesday it would strengthen the rare disease business by introducing Vyvgart, a new treatment for gMG. Handok has signed an agreement with argenx BV to handle the licen
JW Pharmaceutical said Wednesday that a study demonstrating the effectiveness and safety of Hemlibra (emicizumab), a treatment for hemophilia A, in Korean patients, was recently published in the international journal Haemophilia.This is the first time that real-world data evaluating the efficacy and
HK inno.N said it has signed a contract manufacturing agreement (CMO) with Brexogen, a company specializing in exosome therapeutics, to produce cell lines for exosome therapeutics derived from stem cells.The agreement follows a memorandum of understanding signed between the two companies in April.Un
The Coalition for Epidemic Preparedness Innovations (CEPI) highlighted the importance of working on the preparedness stage, emphasizing the need to establish alternative clinical evidence to facilitate rapid vaccine development in alignment with the CEPI's 100-day mission.CEPI's 100-day mission refe
Shin Dong-kun, a dentist-turned-politician, criticized the Yoon Suk Yeol government’s recent decision to slash the research and development (R&D) budget for 2024, at an international bio conference in Seoul.Rep. Shin of the opposition Democratic Party is also the head of the National Assembly’s Heal
Yuhan Corp.'s Leclaza (ingredient: lazertinib) has passed the Cancer Drugs Benefit Appraisal Committee, the first gateway to expanded reimbursement as a first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with an epidermal growth factor receptor (